UBS 3rd Virtual CNS Day

Autifony Therapeutics to participate in the UBS 3rd Virtual CNS Day on June 15; Charles Large (CEO) and Barbara Domayne-Hayman (CBO) will provide an overview of the company and take questions from the audience of investors and pharma companies